Glenmark Pharmaceuticals on Tuesday said it has launched a fixed-dose combination drug for the treatment of Type 2 diabetes in the country.…
pharma
-
-
FDA approved Genentech’s Susvimo, a port delivery system with a customized formulation of Ranibizumab, the active ingredient in Lucentis. Now, the trick for…
-
CompaniesMerck & Co
Merck’s Keytruda Gets EU Approval for Treatment of Triple-Negative Breast Cancer.
by adminby adminThe European Commission has cleared Keytruda (Pembrolizumab) in combination with chemotherapy as a first-line treatment for locally recurrent, unresectable or metastatic TNBC…
-
NPPA fixed the ceiling prices for 12 anti-diabetic generic medicines, including Glimepiride tablets, glucose injection and intermediate acting insulin solution. Drug price…
-
RegulatoryU.S FDA
U.S. Approved Bausch, Clearside XIPERE™ (Triamcinolone Acetonide )Injectable Suspension
by adminby adminBausch Health Companies Inc and Clearside Biomedical Inc said on Monday they received approval from the U.S. health regulator for their…
-
Global Market
Neuland Donepezil Hydrocholoride Becomes the first API to get Certificate of Suitability (CEP)
by adminby adminNeuland announces that The European Directorate for the Quality of Medicines & HealthCare (EDQM) recently granted a Certificate of Suitability (CEP) for Neuland’s API,…
-
ChinaPharma Science & Research
Green Signal for Kintor Pharma, PD-L1/TGF-β dual-targeting antibody (GT90008) for Tumour Clinical Trail from China NMPA
by adminby adminKintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the clinical trial of…
-
Global MarketPharma Science & Research
Himalayan caterpillar fungus possessing Anti- Cancer Activity Shows Potential and Promising Results in Phase 1 Clinical Trial
by adminby adminSynopsis– The chemotherapy has been developed from a molecule found in Himalayan caterpillar fungus and is still in the experimental testing stages. The…
-
Launch
Approaching footsteps by Aptar Pharma and i2c Pharmaceutical Services toward new partnership for co-development and promoting Respitab
by adminby adminSynopsis- Aptar Pharma and i2c Pharmaceutical Services joins hand for co-develop and promote i2c’s pressurized metered dose inhaler (pMDI) technology, Respitab.…
-
Launch
Artificial Intelligence/ Computational Biology Innovation Lab Launched by the Mega Companies AstraZeneca, Merck, Pfizer, Teva, AWS, IBF
by adminby adminKey Points – AION Labs, a first-of-its-kind innovation lab spearheading the adoption of AI technologies and computational science to solve therapeutic challenges,…